South Dakota Investment Council Sells 5,000 Shares of Encompass Health Corporation $EHC

South Dakota Investment Council cut its stake in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 9.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,082 shares of the company’s stock after selling 5,000 shares during the quarter. South Dakota Investment Council’s holdings in Encompass Health were worth $5,720,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Cibc World Market Inc. acquired a new stake in Encompass Health in the third quarter valued at approximately $202,000. Virtus Advisers LLC grew its position in Encompass Health by 16.8% in the 3rd quarter. Virtus Advisers LLC now owns 5,175 shares of the company’s stock valued at $629,000 after purchasing an additional 743 shares during the period. William Blair Investment Management LLC increased its stake in Encompass Health by 1.3% during the 3rd quarter. William Blair Investment Management LLC now owns 1,166,552 shares of the company’s stock valued at $141,724,000 after purchasing an additional 15,467 shares in the last quarter. Allworth Financial LP raised its holdings in Encompass Health by 10.3% during the third quarter. Allworth Financial LP now owns 1,366 shares of the company’s stock worth $166,000 after buying an additional 127 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in shares of Encompass Health by 6.5% in the third quarter. Russell Investments Group Ltd. now owns 108,357 shares of the company’s stock valued at $13,165,000 after buying an additional 6,588 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently weighed in on EHC shares. Barclays raised their price target on shares of Encompass Health from $144.00 to $151.00 and gave the company an “overweight” rating in a research report on Thursday, October 29th. Truist Financial reissued a “buy” rating and set a $156.00 price objective (up from $150.00) on shares of Encompass Health in a report on Friday, October 30th. TD Cowen increased their price objective on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, October 30th. Weiss Ratings upgraded Encompass Health from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Finally, Raymond James Financial reaffirmed a “strong-buy” rating and set a $155.00 target price on shares of Encompass Health in a research report on Friday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $154.25.

Check Out Our Latest Research Report on EHC

Encompass Health Price Performance

Shares of NYSE:EHC opened at $134.93 on Thursday. The company’s 50-day moving average is $127.72 and its 200 day moving average is $112.68. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market capitalization of $13.24 billion, a P/E ratio of 21.08, a price-to-earnings-growth ratio of 2.39 and a beta of 0.83. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $143.90.

Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.52 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.16. Encompass Health had a net margin of 10.17% and a return on equity of 18.35%. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same period in the prior year, the firm earned $1.23 EPS. The company’s revenue was up 8.9% compared to the same quarter last year. On average, equities research analysts forecast that Encompass Health Corporation will post 6.29 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be paid a $0.21 dividend. The ex-dividend date is Monday, January 4th. This represents a $0.84 annualized dividend and a yield of 0.6%. Encompass Health’s dividend payout ratio is presently 13.12%.

Insider Buying and Selling

In other Encompass Health news, EVP John Darby sold 4,858 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,086,714.69. This represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.80% of the company’s stock.

Encompass Health Profile

(Free Report)

Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.

Further Reading

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.